General Anesthesia and Discrete Components of Ketamine Neurophysiology
JAMA Psychiatry - Apr 8, 2026
Back to StakeholdersCentral Michigan University Institute for Integrative Therapies Michener Alex Criddle
Categories
2 domains / 4 areas / 2 specializations
Stanford University
Data updated
United States
10 Trials3 Papers
At the Stanford School of Medicine, researchers from the Rodriguez Lab and the Heifets Lab have united under the banner of the Stanford Psychedelic Science Group. Their primary clinical focus is to investigate compounds including ketamine, psilocybin, and MDMA as potential treatments for debilitating disorders such as obsessive-compulsive disorder (OCD), treatment-resistant depression, and post-traumatic stress disorder (PTSD).
IntroductoryHybridFreeAcademic programmeContinuing educationCurious publicAspiring practitionersLicensed cliniciansResearchers
Blossom’s read
Stanford’s psychedelic education sits squarely in the academic, research-led end of the field rather than the commercial training circuit. It is best for clinicians, trainees, students, and researchers who want a serious grounding in psychedelic medicine, with a clear emphasis on evidence, ethics, and the Stanford research ecosystem. The lineage is strong: the programme is organised through the Stanford Psychedelic Science Group and features faculty and clinicians working in psychiatry, anaesthesiology, and related research areas.
Who is Stanford University for?
Best suited to clinicians, trainees, students, and researchers who want an academically rigorous introduction to psychedelic medicine and the surrounding science. It is less a practitioner certification and more a university-based learning environment for people already in, or heading towards, clinical or research settings.
What do you need before you start?
No formal prerequisite is published for the introductory course pages. The course is taught in a university setting and is framed around academic study and sanctioned research rather than use or facilitation of illicit substances.
Is Stanford University accredited?
Stanford publishes the course through its School of Medicine and Stanford CME infrastructure, but the SPSG education page does not advertise a standalone psychedelic-training certification. Stanford CME offers continuing medical education activities generally, yet no psychedelic-specific CME credit is published on the SPSG education page.
How much does it cost?
Stanford describes the education offering as free high quality education. The SPSG education page does not publish a single programme price for PSYC 215B or related talks, and no tuition, materials fee, or bundle price is listed there.
What do you walk away with?
Learners walk away with an academic introduction to psychedelic medicine, including current research, clinical applications, history, and ethics. The main outcome is knowledge and professional context rather than a separate credential.
Academic Research
3 papersPublished Papers
3
Trial Involvement
10
Distinct Focus Topics
0
Latest Publication
Apr 8, 2026
Recent Papers
iScience - Feb 21, 2026
Magnesium-ibogaine therapy in veterans with traumatic brain injuries
Nature Medicine - Jan 5, 2024
Similar course providers
Reference points selected from shared training modalities, learner audience, level, delivery format, pricing, and location.
- Strong match: 2 shared modalities
- Strong match: 4 shared learner audiences
- Also shares: introductory level
- Also shares: hybrid delivery
- Strong match: 2 shared modalities
- Strong match: 3 shared learner audiences
- Also shares: introductory level
- Also shares: hybrid delivery
- Strong match: 2 shared modalities
- Strong match: 2 shared learner audiences
- Also shares: introductory level
- Also shares: hybrid delivery
- Strong match: 2 shared modalities
- Strong match: 4 shared learner audiences
- Also shares: introductory level
- Also shares: same country: United States
Quick Facts
- Type
- academic
- Founded
- 1885
- HQ
- United States
- Website
- Visit
Research Landscape
What the 10 registered trials Stanford University sponsors or participates in look like when you line them up. Counts come from Blossom’s trial records as of July 2026.
How fast is Stanford University research growing?
SourcedRegistered trials by recorded study-start year. Click a year for the running total.
Don't read as total research effort: only registered trials with a recorded start date are counted (10 of 10 tracked). Recent years under-count because of registration lag; striped bars are still filling in or are planned starts.
What's live right now, and what stopped?
SourcedRegistry status of all 10 Stanford University trials Blossom tracks. Orange marks trials recruiting or opening.
Don't read stopped trials as failures: trials end early for funding, recruitment, and strategy reasons too. Status is as last synced from the registry; some 'recruiting' trials may already have finished.
Which conditions does Stanford University run trials on?
SourcedTrials per primary indication. Orange marks the largest research focus.
Don't read shares as adding to 100%: a trial with several primary indications counts once per indication. Trial volume signals research attention, not evidence quality.
Which compounds appear in Stanford University trials?
SourcedTrials per compound. Orange marks the most-studied compound.
Don't read shares as adding to 100%: a trial testing several compounds counts once per compound, and placebo comparator arms are not shown. Trial volume signals research attention, not evidence quality.